Neogenomics
Depends
Confidence: Medium
NeoGenomics is a publicly traded cancer-diagnostics lab, not software.
New check
Comparison
Neogenomics and Labcorp both land on Depends.
NeoGenomics is a publicly traded cancer-diagnostics lab, not software.
Buy with confidence if you're insured and need routine bloodwork, drug testing, or hospital lab outsourcing.
| Compare | ||
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Oncology practices needing specialty pathology | Insured patients needing routine bloodwork |
| Who it's not for | Anyone shopping for software. This is a lab, not a SaaS tool | Uninsured bargain hunters. Compare cash prices at Quest or online labs first |
| Privacy | No known public vulnerabilities found in the sources reviewed.15 | Settled its 2019 AMCA billing-vendor breach for $35M, paid a $2.3M multistate settlement in Sept 2026, and was hit by SamSam ransomware in 2018. |
| Support quality | Only truncated anecdotes; no support data | BBB complaints dominated by billing disputes |
| Public sentiment | Evidence is mostly employee-side. 498 Glassdoor and 178 Indeed reviews with mixed sentiment.¹ | Patient feedback is mixed: the mobile app and test process draw praise, while billing disputes and support complaints recur. |
| Biggest gotcha | No published prices. Billing runs through insurance and negotiated client contracts; expect opaque invoices13 | A lawsuit alleges Labcorp charged undisclosed high list prices to patients whose insurance was denied. |